At the same time, G6PD overexpression was found to be associated with an increase in mTORC1 activity in blood tumors such as acute myeloid leukemia, and also predicts a poor prognosis (Poulain et al., 2017). This evidence concerns the gene G6PD and acute myeloid leukemia.